Heart Failure Treatment and Management
Heart failure is a clinical syndrome in which the heart cannot pump enough blood to meet the body's demands, affecting tens of millions of people worldwide and accounting for a substantial share of cardiovascular hospitalizations and deaths. Researchers study how to diagnose the condition reliably—using tools like B-type natriuretic peptide, a hormone the stressed heart releases in measurable quantities—and how to translate treatment guidelines into consistent real-world care that reduces both mortality and the high rates of hospital readmission that burden patients and health systems alike. A persistent challenge is understanding how complicating factors, particularly declining kidney function, alter disease progression and blunt the effectiveness of standard therapies. Active work focuses on refining risk prediction models that can identify which patients are most likely to deteriorate, and on closing the gap between what clinical trials demonstrate and what patients actually receive.
- Works
- 101,723
- Total citations
- 1,949,064
- Keywords
- Heart FailureGuidelinesDiagnosisTreatmentB-Type Natriuretic PeptideEpidemiology
Top papers in Heart Failure Treatment and Management
Ordered by total citation count.
- Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.↗ 19,543
- 2013 ACCF/AHA Guideline for the Management of Heart Failure↗ 12,610
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure↗ 12,555OA
- Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?↗ 11,735
- K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification↗ 11,655
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure↗ 11,445OA
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure↗ 9,063OA
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients↗ 8,650OA
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure↗ 8,042OA
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes↗ 7,208OA
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC↗ 6,898OA
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure↗ 6,758OA
Active researchers
Top authors in this area, ranked by h-index.